Diabetes decisions — 2023

The Veteran's diabetes mellitus, type II is presumed to be related to his exposure to herbicide agents during service at Nakhon Phanom Royal Thai Air Force Base in Thailand. The Board granted service connection for this condition.

The Board has remanded the case due to the need for an expert medical opinion regarding whether the Veteran's service-connected disabilities have caused or aggravated his hyperlipidemia, and if so, whether this condition has caused or aggravated any of his other conditions beyond its natural progression.

The Veteran's claim of service connection for migraine headaches is being remanded due to the need for a VA opinion regarding whether his current migraines are caused or aggravated by his service-connected diabetes, hypertension, or PTSD.

The Board has identified a duty-to-assist error in the July 2022 decision and has ordered that the claims for diabetes mellitus and glaucoma of the right eye as secondary to diabetes mellitus be remanded to obtain VA treatment records from 1965 to 2003.

The Veteran's TDIU claim was denied as he did not establish entitlement to a combined rating of at least 70% for his service-connected disabilities prior to February 26, 2020.,The DEA claim was also denied due to the denial of the TDIU claim and the effective date assigned for the TDIU.

The Board has granted service connection for nephrotic syndrome and dismissed the claim for diabetes. The Veteran's nephrotic syndrome is found to be related to in-service exposure to toxic chemicals, while his diabetes was not connected to service.

The Veteran's claims for service connection for diabetes mellitus, type II (DM II) and prostate cancer are remanded due to insufficient information regarding his exposure to herbicide agents during active duty in the Republic of Korea.

The Veteran's diabetes mellitus type II, right arm neuropathy, left arm neuropathy, right leg lower neuropathy, and left leg lower neuropathy are all granted as service connected. The Board found that the Veteran's current conditions were related to his in-service onset of diabetes.

The Board has identified three pre-decisional duty to assist errors and has therefore remanded the claims for further development. Specifically, the AOJ did not attempt to obtain the Veteran's private treatment records, the September 2023 VA Examination for diabetes mellitus is inadequate, and the September 2023 VA Examination for peripheral neuropathy is also inadequate.

Your claim for service connection for diabetes mellitus, type II has been granted and effective since April 2013. However, the appeal is dismissed as moot because no further disagreement was expressed regarding the rating or effective date.

The Board has remanded the claims for ischemic heart disease, arthritis of all joints, diabetes mellitus type II, and bilateral upper and lower extremity peripheral neuropathy due to potential exposure to toxic chemicals during service. The Veteran is also requested to undergo VA examinations to determine the nature, onset, and etiology of his claimed multi-joint arthritis, chronic pain, and gout condition.

The Veteran's service-connected disabilities, including right foot amputation and peripheral neuropathy, have resulted in loss of use of his right foot. The Board has determined that he is eligible for financial assistance to purchase an automobile and adaptive equipment due to this condition.

The Board has denied reopening the claim of service connection for diabetes type I and remanded the issue of assigning a compensable rating for bilateral hearing loss. The Veteran's application to reopen his diabetes type I claim was not successful due to lack of new and material evidence, while the hearing loss case requires further examination.

Your claims for diabetes mellitus, peripheral neuropathy of the bilateral lower extremities, and hypertension have been granted in a March 2023 rating decision. The Board has now dismissed your appeal as there are no longer any issues to consider.

The Board has determined that the Veteran's diabetes mellitus is not service connected due to lack of a current disability. However, his claim for secondary service connection related to obesity and hypertension is remanded as there are insufficient medical opinions provided.

The Board has decided to remand all the Veteran's claims due to incomplete service treatment records and requests for new examinations or medical opinions.

The Veteran's claims for presumptive service connection for diabetes mellitus type 2 and hypertension are granted under the PACT Act. However, due to a remand for further development regarding direct service connection prior to August 10, 2022.

The Board has granted service connection for diabetes mellitus, type II, hypertension, and Parkinson's disease from August 10, 2022. The Veteran was presumed to have been exposed to herbicide agents during his service in Guam between April 1966 and October 1967.

The Board has granted service connection for Parkinson's disease and diabetes mellitus, type II (DM II), both presumed due to herbicide exposure in Thailand. Service connection was denied for left lower extremity diabetic neuropathy and right lower extremity diabetic neuropathy.

The Board has remanded the claims for service connection for diabetes mellitus and ischemic heart disease due to concerns about the accuracy of the USS Ranger's location during a specific date. The Veteran believes he is entitled to presumptive service connection based on his alleged exposure to herbicide agents while aboard the USS Ranger.